CompletedNot Applicable

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

Japan22 participantsStarted 2011-01

Plain-language summary

Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.

Who can participate

Age range40 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms Exclusion Criteria: * The eyes with preretinal or intraretinal hemorrhage at the fovea * The patients with follow-up less than 3 months

What they're measuring

Displacement of sub macular hemorrhage

Timeframe: one year

Trial details

NCT IDNCT02120066

SponsorKyorin University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-06

View on ClinicalTrials.gov More Submacular Hemorrhage trials